Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


18.12.2017

1 Clin Microbiol Rev
1 Infect Immun
1 J Immunol
1 J Infect Dis
4 J Virol
1 JAMA
1 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
3 Pediatr Infect Dis J
1 PLoS One
1 Proc Natl Acad Sci U S A
16 Vaccine
2 Virology
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Microbiol Rev

  1. POWERS AM
    Vaccine and Therapeutic Options To Control Chikungunya Virus.
    Clin Microbiol Rev. 2017;31.
    PubMed     Text format     Abstract available


    Infect Immun

  2. LACEY KA, Leech JM, Lalor SJ, McCormack N, et al
    The Staphylococcus aureus cell wall-anchored protein clumping factor A is an important T cell antigen.
    Infect Immun. 2017 Sep 25. pii: IAI.00549-17. doi: 10.1128/IAI.00549.
    PubMed     Text format     Abstract available


    J Immunol

  3. AMODIO D, Cotugno N, Macchiarulo G, Rocca S, et al
    Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination.
    J Immunol. 2017 Dec 13. pii: jimmunol.1701312. doi: 10.4049/jimmunol.1701312.
    PubMed     Text format     Abstract available


    J Infect Dis

  4. MADARAS-KELLY K, Remington R, Hruza H, Xu D, et al
    The Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines in Preventing Post-Influenza Deaths.
    J Infect Dis. 2017 Dec 9. pii: 4718125. doi: 10.1093.
    PubMed     Text format    


    J Virol

  5. WONG TM, Allen JD, Bebin-Blackwell AG, Carter DM, et al
    COBRA HA elicits hemagglutination-inhibition antibodies against a panel of H3N2 influenza virus co-circulating variants.
    J Virol. 2017 Oct 4. pii: JVI.01581-17. doi: 10.1128/JVI.01581.
    PubMed     Text format     Abstract available

  6. CARTER DM, Darby CA, Johnson SK, Carlock MA, et al
    Elicitation of protective antibodies against a broad panel of H1N1 viruses in ferrets pre-immune to historical H1N1 influenza viruses.
    J Virol. 2017 Oct 4. pii: JVI.01283-17. doi: 10.1128/JVI.01283.
    PubMed     Text format     Abstract available

  7. REIS AL, Goatley LC, Jabbar T, Sanchez-Cordon PJ, et al
    Deletion of the African Swine Fever Virus Gene DP148R Does Not Reduce Virus Replication in Culture but Reduces Virus Virulence in Pigs and Induces High Levels of Protection against Challenge.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available

  8. MONTEAGUDO PL, Lacasta A, Lopez E, Bosch L, et al
    BA71DeltaCD2: a New Recombinant Live Attenuated African Swine Fever Virus with Cross-Protective Capabilities.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    JAMA

  9. ABBASI J
    First Phase 1 Trial of a Prophylactic mRNA Vaccine Reported.
    JAMA. 2017;318:2173.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  10. ZHAO D, Ma R, Zhou T, Yang F, et al
    Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis - Beijing, China, 2014-2016.
    MMWR Morb Mortal Wkly Rep. 2017;66:1357-1361.
    PubMed     Text format     Abstract available


    N Engl J Med

  11. WEBBER BJ, Duncan JR, Costello AA
    Third Dose of MMR Vaccine for Mumps Control.
    N Engl J Med. 2017;377:2402-3.
    PubMed     Text format    

  12. JENT P, Olah A, Sommerstein R
    Third Dose of MMR Vaccine for Mumps Control.
    N Engl J Med. 2017;377:2402.
    PubMed     Text format    

  13. OSTERGAARD L, Vesikari T, Absalon J, Beeslaar J, et al
    A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults.
    N Engl J Med. 2017;377:2349-2362.
    PubMed     Text format     Abstract available


  14. Third Dose of MMR Vaccine for Mumps Control.
    N Engl J Med. 2017;377:2402-2403.
    PubMed     Text format    


    Pediatr Infect Dis J

  15. BADAHDAH AM, Khatami A, Tashani M, Rashid H, et al
    Evidence for Rise in Meningococcal Serogroup C Bactericidal Antibody Titers in the Absence of Booster Vaccination in Previously Vaccinated Children.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001861.
    PubMed     Text format     Abstract available

  16. RYBAK A, Levy C, Bonacorsi S, Bechet S, et al
    Antibiotic Resistance of Potential Otopathogens Isolated from Nasopharyngeal Flora of Children with Acute Otitis Media Before, During and After Pneumococcal Conjugate Vaccines Implementation.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001862.
    PubMed     Text format     Abstract available

  17. BLACK S
    Editor's Commentary: Vaccines as a Tool to Combat Antibiotic Resistance.
    Pediatr Infect Dis J. 2018;37:96.
    PubMed     Text format    


    PLoS One

  18. RAJARAM S, Wiecek W, Lawson R, Blak BT, et al
    Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approach.
    PLoS One. 2017;12:e0186739.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  19. PANANOS AD, Bury TM, Wang C, Schonfeld J, et al
    Critical dynamics in population vaccinating behavior.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1704093114.
    PubMed     Text format     Abstract available


    Vaccine

  20. HERBECK JT, Peebles K, Edlefsen PT, Rolland M, et al
    HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31731.
    PubMed     Text format     Abstract available

  21. HABER P, Moro PL, Ng C, Lewis PW, et al
    Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31722.
    PubMed     Text format     Abstract available

  22. CISZEWSKI A
    Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases.
    Vaccine. 2018;36:202-206.
    PubMed     Text format     Abstract available

  23. MARTINSON B, Zoghby W, Barrett K, Bryson L, et al
    Efficacy of an inactivated Mycoplasma hyorhinis vaccine in pigs.
    Vaccine. 2017 Dec 5. pii: S0264-410X(17)31660.
    PubMed     Text format     Abstract available

  24. ORTIZ JR, Hickling J, Jones R, Donabedian A, et al
    Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016.
    Vaccine. 2017 Dec 5. pii: S0264-410X(17)31645.
    PubMed     Text format     Abstract available

  25. BOEF AGC, van der Klis FRM, Berbers GAM, Buisman AM, et al
    Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies.
    Vaccine. 2017 Dec 6. pii: S0264-410X(17)31697.
    PubMed     Text format     Abstract available

  26. KIM SK, Park HY, Kim SH
    A third dose of measles vaccine is needed in young Korean health care workers.
    Vaccine. 2017 Dec 6. pii: S0264-410X(17)31720.
    PubMed     Text format    

  27. NONVIGNON J, Atherly D, Pecenka C, Aikins M, et al
    Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031.
    Vaccine. 2017 Dec 6. pii: S0264-410X(17)31723.
    PubMed     Text format     Abstract available

  28. NUNN A, Campbell AC, Naus M, Kwong JC, et al
    Implementing a province-wide mandatory vaccinate-or-mask policy at healthcare facilities in British Columbia, Canada.
    Vaccine. 2017 Dec 6. pii: S0264-410X(17)31713.
    PubMed     Text format     Abstract available

  29. KOBAYASHI M, Adachi N, Miyazaki M, Tatsumi M, et al
    Decline of rotavirus-coded hospitalizations in children under 5 years: A report from Japan where rotavirus vaccines are self-financed.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31441.
    PubMed     Text format     Abstract available

  30. DUBE E, Gagnon D, Ouakki M, Bettinger JA, et al
    Measuring vaccine acceptance among Canadian parents: A survey of the Canadian Immunization Research Network.
    Vaccine. 2017 Dec 9. pii: S0264-410X(17)31732.
    PubMed     Text format     Abstract available

  31. ZENG W, Halasa-Rappel YA, Baurin N, Coudeville L, et al
    Cost-effectiveness of dengue vaccination in ten endemic countries.
    Vaccine. 2017 Dec 8. pii: S0264-410X(17)31663.
    PubMed     Text format     Abstract available

  32. HENRY O, Brzostek J, Czajka H, Leviniene G, et al
    One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
    Vaccine. 2017 Dec 7. pii: S0264-410X(17)31724.
    PubMed     Text format     Abstract available

  33. GOTTLIEB SL, Giersing BK, Hickling J, Jones R, et al
    Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017.
    Vaccine. 2017 Dec 7. pii: S0264-410X(17)31492.
    PubMed     Text format     Abstract available

  34. DE WALS P, Lefebvre B, Deceuninck G, Longtin J, et al
    Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
    Vaccine. 2017 Dec 7. pii: S0264-410X(17)31618.
    PubMed     Text format     Abstract available

  35. RABENSTEINER A, Buja A, Regele D, Fischer M, et al
    Healthcare worker's attitude to seasonal influenza vaccination in the South Tyrolean province of Italy: barriers and facilitators.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31734.
    PubMed     Text format     Abstract available


    Virology

  36. HERRERA-RODRIGUEZ J, Meijerhof T, Niesters HG, Stjernholm G, et al
    A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model.
    Virology. 2017;515:21-28.
    PubMed     Text format     Abstract available

  37. DIAZ F, Gregory S, Nakashima H, Viapiano MS, et al
    Intramuscular delivery of replication-defective herpes simplex virus gives antigen expression in muscle syncytia and improved protection against pathogenic HSV-2 strains.
    Virology. 2017;513:129-135.
    PubMed     Text format     Abstract available


    Virus Res

  38. KIM SC, Won YH, Park JS, Jeon JS, et al
    Vaccine-Type Mutations Identified in Varicella Zoster Virus Passaged in Cell Culture.
    Virus Res. 2017 Dec 11. pii: S0168-1702(17)30833.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: